NCT07890194 Effectiveness of Individualized Pelvic Floor Muscle Rehabilitation in Addition to Standard Urotherapy and Alarm Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis
| NCT ID | NCT07890194 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Primary Monosymptomatic Nocturnal Enuresis |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-08-31 |
| Primary Completion | 2028-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-08-31 with a primary completion date of 2028-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate whether adding individualized pelvic floor muscle rehabilitation to standard urotherapy and alarm treatment improves bedwetting in children aged 5-18 years with primary monosymptomatic nocturnal enuresis. Participants will be randomly assigned to two groups. Both groups will receive standard urotherapy and alarm treatment. One group will also receive pelvic floor muscle rehabilitation for 12 weeks. The study will compare dry nights, alarm activations, and changes in pelvic floor muscle function between the groups.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of primary monosymptomatic nocturnal enuresis (PMNE) according to the International Children's Continence Society (ICCS) diagnostic criteria. * Age between 5 and 18 years. * Willingness to participate in the study and provision of written informed consent by a parent or legal guardian. * Recommendation of enuresis alarm therapy as a first-line treatment. Exclusion Criteria: * Presence of cognitive or intellectual impairment. * Enuresis attributable to anatomical or neurological causes. * Receipt of nonpharmacological treatment for enuresis, such as standard urotherapy, alarm therapy, pelvic floor muscle training, or electrical stimulation, within the preceding six months.
Contact & Investigator
Türkan AKBAYRAK, Prof. Dr.
STUDY DIRECTOR
Hacettepe University
Frequently Asked Questions
Who can join the NCT07890194 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Primary Monosymptomatic Nocturnal Enuresis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07890194 currently recruiting?
Yes, NCT07890194 is actively recruiting participants. Contact the research team at cananseyhan@gmail.com for enrollment information.
Where is the NCT07890194 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07890194 clinical trial?
NCT07890194 is sponsored by Hacettepe University. The principal investigator is Türkan AKBAYRAK, Prof. Dr. at Hacettepe University. The trial plans to enroll 30 participants.